Healthcare -
Biotechnology - NASDAQ - US
$ 36.91
0.819 %
$ 3.49 B
Market Cap
-6.33
P/E
RARE - TOTAL EQUITY
Total Equity RARE - Ultragenyx Pharmaceutical Inc.
262 M
LAST VALUE
-13.74%
2 YEAR CAGR
-16.69%
5 YEAR CAGR
3.56%
10 YEAR CAGR